AstraZeneca PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZN New York 2834 www.astrazeneca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca PLC

Here’s What Lifted AstraZeneca PLC (AZN) in Q4 - Feb 12th, 2026 7:13 am
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event - Feb 12th, 2026 6:55 am
Upstream Bio’s stock drops 47% on verekitug Phase II asthma data - Feb 12th, 2026 5:55 am
Sanofi says board has removed CEO Paul Hudson - Feb 12th, 2026 2:36 am
AstraZeneca PLC (AZN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Feb 11th, 2026 6:04 pm
Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica - Feb 11th, 2026 9:49 am
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading - Feb 11th, 2026 9:05 am
Citi maintains 'buy' on AstraZeneca with £170 target, cites sector-best pipeline - Feb 11th, 2026 8:45 am
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US - Feb 11th, 2026 7:00 am
Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? - Feb 11th, 2026 6:09 am
Moderna shares fall as FDA declines to review new flu vaccine - Feb 11th, 2026 4:44 am
Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill - Feb 11th, 2026 2:33 am
AstraZeneca’s DATROWAY Review And China Moves Shape Valuation Debate - Feb 11th, 2026 1:17 am
AstraZeneca Reiterates $80 Billion 2030 View Ahead Of 'Catalyst-Rich 2026' - Feb 10th, 2026 2:10 pm
AstraZeneca Q4 Earnings Call Highlights - Feb 10th, 2026 1:49 pm
AstraZeneca bets on continued oncology demand for 2026 growth - Feb 10th, 2026 10:02 am
AstraZeneca to advance in-licensed oral GLP-1RA to pivotal trials - Feb 10th, 2026 9:27 am
European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading - Feb 10th, 2026 9:10 am
Jim Cramer Says “The Street Has Decided That S&P Global Isn’t Worth as Much as We Thought” - Feb 10th, 2026 8:59 am
Jim Cramer on Datadog: “There Are Cheap Enterprise Software Stocks, Just Not This One” - Feb 10th, 2026 8:59 am